RheoMeditech Inc., founded in 2003, specializes in blood test in-vitro diagnostic device and has developed by publishing a number of technical and clinical papers to the international Association. 

We seek to improve human health and healthcare. Based on our advanced technology, we commercialized RheoScan, the world's first clinical blood circulation system in 2007 and is using it as a diagnostic technology for diabetes microvascular diseases. 

In 2019, Anysis, the Platelet Complex Function Analyzer, was commercialized and we were able to perform five tests such as the ADP, Epi, and Aspirin test. 

​

In 2020, RheoESR, which can measure ESR(Erythrocyte Sedimentation rate) in 20 seconds, is almost ready to be out in the medical field. 60 test tubes can be inserted. 

We provide what patients need now. 

Small but Strong,

RheoMeditech.

​

Please feel free to contact us about our product or any inquiries.